Table 2

Baseline (year 1) phenotype characteristics prior to COPD diagnosis

VariablesPhenotype
A (n=4339)B (n=1040)C (n=6103)
Age, mean (SD), years69 (9)73 (8)68 (10)
Sex, male, no. (%)2456 (57)799 (77)3271 (54)
Body mass index, mean (SD), kg/m227 (6)29 (5)27 (5)
Body mass index, no. (%) with data4311 (99)1040 (100)6058 (99)
 Underweight1618 (38)220 (21)2228 (37)
 Normal weight1029 (24)381 (37)1460 (24)
 Overweight1479 (34)427 (41)2164 (36)
 Obese185 (4)12 (1)206 (3)
Smoking status, no. (%)
 Active smoker1542 (36)306 (29)2619 (43)
 Former smoker2797 (64)734 (71)3484 (57)
COPD severity, no. (%) with data2481 (57)556 (54)2822 (46)
 Mild587 (24)174 (31)1196 (42)
 Moderate1154 (46)316 (57)1361 (48)
 Severe666 (27)62 (11)247 (9)
 Very severe74 (3)4 (1)18 (1)
COPD exacerbations in the past year, mean (SD)0.5 (1.2)0.2 (0.7)0.1 (0.8)
COPD exacerbations in the past year, no. (%)
 03323 (77)899 (86)5514 (90)
 1497 (11)85 (8)416 (7)
 2266 (6)36 (4)131 (2)
 >2253 (6)20 (2)42 (1)
Forced expiratory volume in 1 s, mean (SD), L0.7 (0.2)0.7 (0.2)0.8 (0.2)
Emphysema, no. (%)308 (7)59 (6)279 (5)
Diabetes, no. (%)597 (14)382 (37)792 (13)
Hypertension, no. (%)1948 (45)703 (68)2666 (44)
Coronary artery disease, no. (%)33 (1)617 (59)25 (0.4)
Acute myocardial infarction, no. (%)75 (2)681 (66)66 (1)
Congestive cardiac failure, no. (%)223 (5)304 (29)192 (3)
Anxiety, no. (%)319 (7)101 (10)518 (9)
Depression, no. (%)1279 (30)348 (34)1863 (31)
Treatment, no. (%)
 ICS4290 (99)408 (39)384 (6)
 ICS+LABA4141 (95)339 (33)6 (0.1)
 LAMA3022 (70)437 (42)1904 (31)
 LABA227 (5)92 (9)780 (12.8)
 SAMA206 (5)64(6)311 (5)
 Mucolytics756 (17)108 (10)164 (23)
  • COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; LABA, long-acting beta agonist; LAMA, long-acting antimuscarinic; SAMA, short-acting antimuscarinic.